- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Founded in 2019, Asston Pharmaceuticals Limited manufactures and exports pharmaceutical formulations and nutraceuticals under the "Asston" brand, utilizing a diversified business model that includes direct sales, contract manufacturing, and export primarily to African markets.
Asston Pharmaceuticals' Board has approved the allotment of 2.41 Cr equity shares at Rs. 115 each, including a premium of Rs. 105. This preferential issue was made to 15 investors. Following this allotment, the company's paid-up equity share capital has increased to Rs. 10.92 Cr, comprising 1.09 Cr shares of...
Asston Pharmaceuticals' board has approved several key corporate actions. This includes appointing M/s Yash A. Jain & Associates as Internal Auditor and M/s Panchal S K & Associates as Statutory Auditors. The board also proposes the re-appointment of Mr. Ashish Narayan Sakalkar as Managing Director, subject to shareholder approval. Additionally,...
The company has announced a board meeting on October 26. The key agenda for this meeting is to review and approve the financial results for the quarter and half-year. This is a crucial update for investors, offering insights into the company's recent operational and financial performance. Additionally, the Board will...